Abiopharma

🔍 WILLIS CHARLES F IV (Executive)

Company: WILLIS LEASE FINANCE CORP (WLFC)

Report Date: 2026-03-18

Detailed Transactions and Holdings:

• Sold 238 shares of Common Stock at $167.5501 per share (Direct)
  Date: 2026-03-18 | Code: S | equity_swap_involved: false | shares_owned_after: 13,560.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,859 shares of Common Stock at $162.5404 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: false | shares_owned_after: 931,375.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 1,205 shares of Common Stock at $163.3944 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: false | shares_owned_after: 930,170.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 1,235 shares of Common Stock at $164.3783 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: false | shares_owned_after: 928,935.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 1,091 shares of Common Stock at $166.7082 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: false | shares_owned_after: 927,844.00 | transaction_form_type: 4 | Footnotes: F5
• Sold 331 shares of Common Stock at $167.987 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: false | shares_owned_after: 927,513.00 | transaction_form_type: 4 | Footnotes: F6
• Sold 945 shares of Common Stock at $165.1134 per share (Direct)
  Date: 2026-03-31 | Code: S | equity_swap_involved: false | shares_owned_after: 926,568.00 | transaction_form_type: 4 | Footnotes: F7
• Sold 600 shares of Common Stock at $166.51 per share (Direct)
  Date: 2026-03-31 | Code: S | equity_swap_involved: false | shares_owned_after: 925,968.00 | transaction_form_type: 4 | Footnotes: F8
• Sold 1,300 shares of Common Stock at $169.5217 per share (Direct)
  Date: 2026-03-31 | Code: S | equity_swap_involved: false | shares_owned_after: 924,668.00 | transaction_form_type: 4 | Footnotes: F9
• Sold 437 shares of Common Stock at $170.4882 per share (Direct)
  Date: 2026-03-31 | Code: S | equity_swap_involved: false | shares_owned_after: 924,231.00 | transaction_form_type: 4 | Footnotes: F10
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-18 | Code: H | nature_of_ownership: CFW Partners | shares_owned_after: 2,134,148.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-18 | Code: H | nature_of_ownership: Granddaughter | shares_owned_after: 584.00 | Footnotes: F11

Footnotes:

• F1: Charlotte Montressor Willis.
• F2: This transaction was executed in multiple trades at prices ranging from $161.91 to $162.90, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) of this Form 4.
• F3: This transaction was executed in multiple trades at prices ranging from $163.00 to $163.975, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) of this Form 4.
• F4: This transaction was executed in multiple trades at prices ranging from $164.01 to $164.81, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) of this Form 4.
• F5: This transaction was executed in multiple trades at prices ranging from $166.41 to $167.12, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in footnote (5) of this Form 4.
• F6: This transaction was executed in multiple trades at prices ranging from $167.50 to $168.36, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in footnote (6) of this Form 4.
• F7: This transaction was executed in multiple trades at prices ranging from $164.97 to $165.46, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in footnote (7) of this Form 4.
• F8: This transaction was executed in multiple trades at prices ranging from $166.10 to $166.90, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in footnote (8) of this Form 4.
• F9: This transaction was executed in multiple trades at prices ranging from $169.005 to $170.00, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in footnote (9) of this Form 4.
• F10: This transaction was executed in multiple trades at prices ranging from $170.09 to $170.67, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in footnote (10) of this Form 4.
• F11: Wilder Grace Willis 2016 Trust.